Planned Cesarean or planned vaginal delivery for twins: a secondary analysis of a randomized controlled trial.
To evaluate whether there is a differential benefit from planned cesarean delivery (CD) for women with a twin pregnancy and a cephalic-presenting first twin; depending on a pre-specified list of maternal and pregnancy characteristics (markers), and/or gestational age (GA) at delivery. We performed a secondary analysis of the Twin Birth Study (TBS) including 2,804 women with a twin pregnancy with a cephalic-presenting first twin between GA of 32+0 and 38+6 weeks in 106 centres in 25 countries. We built a separate logistic regression model for each marker to model the composite outcome as function of the specific marker, planned delivery mode, and marker-by-planned-delivery-mode-interaction, and furthermore performed multivariable logistic regression with backward variable elimination separately in each trial arm. Markers considered were maternal age, parity, history of previous CD, use of antenatal corticosteroids, estimated fetal weight (EFW) of twin A, EFW of twin B, >25% difference in EFW of the twins, presentation of twin B, chorionicity on ultrasound, method of conception, complications of pregnancy, ruptured membranes at randomization and GA at randomization. The main outcome measure was a composite adverse perinatal outcome (perinatal death or serious neonatal morbidity). None of the studied baseline markers was associated with differential benefit from planned CD. GA at delivery was differentially associated with the outcome in the treatment arms (p for interaction 0.001). GA at delivery was differentially associated with the outcome in the treatment arms (p for interaction 0.001). For GA 32+0- 36+6 weeks, VD was associated with fewer adverse outcomes compared to CD (OR 0.62; 95% CI 0.37-1.03). At ≥ 37+0 weeks, 10 (1%) newborns suffered the composite perinatal outcome after planned CD versus 23 (2%) after planned VD (OR 2.25; 95% CI 1.06-4.77). Neonatal outcomes of twin pregnancies with the first twin in cephalic position may differ depending on GA and planned mode of delivery. From 32-37 weeks a planned VD seems favorable, while from around 37 weeks on, a CD might be safer. The absolute risks at term are low and must be weighed against the increased maternal risks associated with planned CD. Clinical Trial registration Twin Birth study: (NCT00187369; https://clinicaltrials.gov/ct2/show/NCT00187369, ISRCTN74420086 https://www.isrctn.com/ISRCTN74420086?q=ISRCTN74420086&filters=&sort=&offset=1&totalResults=1&page=1&pageSize=10&searchType=basic-search) This article is protected by copyright. All rights reserved.